The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
- PMID: 37714384
- DOI: 10.1016/j.arr.2023.102075
The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Abstract
Parkinson disease (PD) is a progressive neurodegenerative disease (NDD) of the brain. It has been reported that prolactin (PRL) hormone plays a differential effect in PD, may be increasing, reduced or unaffected. PRL level is dysregulated in different neurodegenerative disorders including PD. Preclinical and clinical studies pointed out that PRL may has a neuroprotective against PD neuropathology . Though, the mechanistic role of PRL in PD is not fully elucidated. Therefore, the objective of the present review was to clarify the potential role and mechanistic pathway of PRL in PD neuropathology. The present review highlighted that PRL appears to have a neuroprotective effect against PD neuropathology by inhibiting the expression of pro-inflammatory signaling pathways, antioxidant effects and by inhibiting neuroinflammation. Thus, preclinical and clinical studies are warranted in this regard.
Keywords: Ageing disorders; Cognitive dysfunction; Parkinson disease; Prolactin; Sleep disorders.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflicts of interest.
Similar articles
-
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.Inflammopharmacology. 2023 Apr;31(2):673-688. doi: 10.1007/s10787-023-01192-2. Epub 2023 Mar 24. Inflammopharmacology. 2023. PMID: 36961665 Review.
-
Glial cells as mediators of protective actions of prolactin (PRL) in the CNS.Gen Comp Endocrinol. 2018 Sep 1;265:106-110. doi: 10.1016/j.ygcen.2018.01.024. Epub 2018 Jan 31. Gen Comp Endocrinol. 2018. PMID: 29378204 Review.
-
Post-treatment with prolactin protects hippocampal CA1 neurons of the ovariectomized female rat against kainic acid-induced neurodegeneration.Neuroscience. 2016 Jul 22;328:58-68. doi: 10.1016/j.neuroscience.2016.04.030. Epub 2016 Apr 25. Neuroscience. 2016. PMID: 27126559
-
The Mechanistic Role of Thymoquinone in Parkinson's Disease: Focus on Neuroprotection in Pre-Clinical Studies.Curr Mol Pharmacol. 2021;14(6):1083-1092. doi: 10.2174/1874467214666210105140944. Curr Mol Pharmacol. 2021. PMID: 33402092 Review.
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
Cited by
-
Molecular Signaling Pathways of Quercetin in Alzheimer's Disease: A Promising Arena.Cell Mol Neurobiol. 2024 Dec 24;45(1):8. doi: 10.1007/s10571-024-01526-w. Cell Mol Neurobiol. 2024. PMID: 39719518 Free PMC article. Review.
-
Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.Mol Biol Rep. 2024 May 24;51(1):669. doi: 10.1007/s11033-024-09587-2. Mol Biol Rep. 2024. PMID: 38787465
-
Role of fenofibrate in multiple sclerosis.Eur J Med Res. 2024 Feb 9;29(1):113. doi: 10.1186/s40001-024-01700-2. Eur J Med Res. 2024. PMID: 38336772 Free PMC article. Review.
-
Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint.Mol Neurobiol. 2025 Jun 5. doi: 10.1007/s12035-025-05113-y. Online ahead of print. Mol Neurobiol. 2025. PMID: 40474025 Review.
-
The role of statins in amyotrophic lateral sclerosis: protective or not?Front Neurosci. 2024 Jun 5;18:1422912. doi: 10.3389/fnins.2024.1422912. eCollection 2024. Front Neurosci. 2024. PMID: 38903602 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical